These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3781190

  • 1. Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis.
    Czaja AJ, Beaver SJ, Shiels MT.
    Gastroenterology; 1987 Jan; 92(1):215-9. PubMed ID: 3781190
    [Abstract] [Full Text] [Related]

  • 2. Prognosis of corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis in postmenopausal women: a retrospective analysis.
    Wang KK, Czaja AJ.
    Gastroenterology; 1989 Nov; 97(5):1288-93. PubMed ID: 2792661
    [Abstract] [Full Text] [Related]

  • 3. Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis.
    Davis GL, Czaja AJ, Ludwig J.
    Gastroenterology; 1984 Dec; 87(6):1222-7. PubMed ID: 6489694
    [Abstract] [Full Text] [Related]

  • 4. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis.
    Czaja AJ, Davis GL, Ludwig J, Taswell HF.
    Hepatology; 1984 Dec; 4(4):622-7. PubMed ID: 6745850
    [Abstract] [Full Text] [Related]

  • 5. Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis.
    Czaja AJ.
    Hepatology; 1990 Jun; 11(6):1044-9. PubMed ID: 2365282
    [Abstract] [Full Text] [Related]

  • 6. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis.
    Czaja AJ, Menon KV, Carpenter HA.
    Hepatology; 2002 Apr; 35(4):890-7. PubMed ID: 11915036
    [Abstract] [Full Text] [Related]

  • 7. Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission.
    Czaja AJ, Ammon HV, Summerskill WH.
    Gastroenterology; 1980 Mar; 78(3):518-23. PubMed ID: 7351290
    [Abstract] [Full Text] [Related]

  • 8. Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis.
    Czaja AJ, Rakela J, Hay JE, Moore SB.
    Gastroenterology; 1990 Jun; 98(6):1587-93. PubMed ID: 2338197
    [Abstract] [Full Text] [Related]

  • 9. Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis.
    Czaja AJ, Hay JE, Rakela J.
    Mayo Clin Proc; 1990 Jan; 65(1):23-30. PubMed ID: 2296210
    [Abstract] [Full Text] [Related]

  • 10. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology.
    Czaja AJ, Davis GL, Ludwig J, Baggenstoss AH, Taswell HF.
    Gastroenterology; 1983 Sep; 85(3):713-7. PubMed ID: 6192038
    [Abstract] [Full Text] [Related]

  • 11. Oral pulse prednisone therapy in the treatment of HBsAg negative chronic active hepatitis.
    Chase WF, Winn RE, Mayes GR.
    Gastroenterology; 1982 Dec; 83(6):1292-6. PubMed ID: 7129032
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Frequency and significance of serum alpha-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis.
    Czaja AJ, Beaver SJ, Wood JR, Klee GG, Go VL.
    Gastroenterology; 1987 Oct; 93(4):687-92. PubMed ID: 2442060
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H, Fay O, Roldán L, Vorovioff J.
    Acta Gastroenterol Latinoam; 1982 Oct; 12(4):323-32. PubMed ID: 7185230
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus deoxyribonucleic acid in serum during hepatitis B e antigen clearance in corticosteroid-treated severe chronic active hepatitis B.
    Wood JR, Czaja AJ, Taswell HF, Ludwig J, Rakela J, Chase R.
    Gastroenterology; 1987 Dec; 93(6):1225-30. PubMed ID: 3678739
    [Abstract] [Full Text] [Related]

  • 20. Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B.
    Papatheodoridis GV, Manolakopoulos S, Su TH, Siakavellas S, Liu CJ, Kourikou A, Yang HC, Kao JH.
    Hepatology; 2018 Aug; 68(2):415-424. PubMed ID: 28859219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.